Literature DB >> 15632059

Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures.

George Zachos1, Michael D Rainey, David A F Gillespie.   

Abstract

We investigated mitotic delay during replication arrest (the S-M checkpoint) in DT40 B-lymphoma cells deficient in the Chk1 or Chk2 kinase. We show here that cells lacking Chk1, but not those lacking Chk2, enter mitosis with incompletely replicated DNA when DNA synthesis is blocked, but only after an initial delay. This initial delay persists when S-M checkpoint failure is induced in Chk2-/- cells with the Chk1 inhibitor UCN-01, indicating that it does not depend on Chk1 or Chk2 activity. Surprisingly, dephosphorylation of tyrosine 15 did not accompany Cdc2 activation during premature entry to mitosis in Chk1-/- cells, although mitotic phosphorylation of cyclin B2 did occur. Previous studies have shown that Chk1 is required to stabilize stalled replication forks during replication arrest, and strikingly, premature mitosis occurs only in Chk1-deficient cells which have lost the capacity to synthesize DNA as a result of progressive replication fork inactivation. These results suggest that Chk1 maintains the S-M checkpoint indirectly by preserving the viability of replication structures and that it is the continued presence of such structures, rather than the activation of Chk1 per se, which delays mitosis until DNA replication is complete.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632059      PMCID: PMC543419          DOI: 10.1128/MCB.25.2.563-574.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  The G2-phase DNA-damage checkpoint.

Authors:  M J O'Connell; N C Walworth; A M Carr
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 2.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

Authors:  C G Takizawa; D O Morgan
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

3.  Basis for the checkpoint signal specificity that regulates Chk1 and Cds1 protein kinases.

Authors:  J M Brondello; M N Boddy; B Furnari; P Russell
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

4.  Mik1 levels accumulate in S phase and may mediate an intrinsic link between S phase and mitosis.

Authors:  P U Christensen; N J Bentley; R G Martinho; O Nielsen; A M Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Roles of the mitotic inhibitors Wee1 and Mik1 in the G(2) DNA damage and replication checkpoints.

Authors:  N Rhind; P Russell
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.

Authors:  P R Graves; L Yu; J K Schwarz; J Gales; E A Sausville; P M O'Connor; H Piwnica-Worms
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

Authors:  H Takai; K Tominaga; N Motoyama; Y A Minamishima; H Nagahama; T Tsukiyama; K Ikeda; K Nakayama; M Nakanishi; K Nakayama
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

9.  The G(2) DNA damage checkpoint targets both Wee1 and Cdc25.

Authors:  J M Raleigh; M J O'Connell
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

Review 10.  Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways.

Authors:  N Rhind; P Russell
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  45 in total

Review 1.  Pathways of mammalian replication fork restart.

Authors:  Eva Petermann; Thomas Helleday
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-15       Impact factor: 94.444

2.  Pot1 and cell cycle progression cooperate in telomere length regulation.

Authors:  Dmitri Churikov; Carolyn M Price
Journal:  Nat Struct Mol Biol       Date:  2007-12-09       Impact factor: 15.369

3.  Chk1 is required for spindle checkpoint function.

Authors:  George Zachos; Elizabeth J Black; Mark Walker; Mary T Scott; Paola Vagnarelli; William C Earnshaw; David A F Gillespie
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

4.  ATR activation and replication fork restart are defective in FANCM-deficient cells.

Authors:  Rebekka A Schwab; Andrew N Blackford; Wojciech Niedzwiedz
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

Review 5.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

6.  Role of Chk1 in the differentiation program of hematopoietic stem cells.

Authors:  Laura Carrassa; Elisa Montelatici; Lorenza Lazzari; Stefano Zangrossi; Matteo Simone; Massimo Broggini; Giovanna Damia
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

7.  Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.

Authors:  Lei Duan; Ricardo E Perez; Michael Hansen; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

8.  Chk1 and Claspin potentiate PCNA ubiquitination.

Authors:  Xiaohong H Yang; Bunsyo Shiotani; Marie Classon; Lee Zou
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

9.  Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment.

Authors:  Yiduo Hu; Xincheng Lu; Guangjin Zhou; Ellen L Barnes; Guangbin Luo
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

10.  Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.

Authors:  M Walker; E J Black; V Oehler; D A Gillespie; M T Scott
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.